ReCAP: Hospitalizations in Older Adults With Advanced Cancer: The Role of Chemotherapy
- PMID: 26869655
- PMCID: PMC5702789
- DOI: 10.1200/JOP.2015.004812
ReCAP: Hospitalizations in Older Adults With Advanced Cancer: The Role of Chemotherapy
Abstract
Purpose: Hospital readmissions are often cited as a marker of poor quality of care. Limited data suggest some readmissions may be preventable depending upon definitions and available outpatient support.
Methods: General criteria to define preventable and not preventable admissions were developed before data collection began. The records of sequential nonsurgical oncology readmissions were reviewed independently by two reviewers. When the reviewers disagreed about assigning admissions as preventable or not preventable, a third reviewer was the tie breaker. The reasons for assigning admissions as preventable or not preventable were analyzed.
Results: Seventy-two readmissions occurring among 69 patients were analyzed. The first two reviewers agreed that 18 (25%) of 72 were preventable and that 29 (40%) of 72 were not. A third reviewer found four of the split 25 cases to be preventable; therefore, the consensus preventability rate was 22 (31%) of 72. The most common causes of preventability were overwhelming symptoms in patients who qualified for hospice but were not participating in hospice and insufficient communication between patients and the care team about symptom burden. The most common reason for assignment of a not preventable admission was a high symptom burden among patients without strong indications for hospice or for whom aggressive outpatient management was inadequate. The median survival after readmission was 72 days.
Conclusion: A substantial proportion of oncology readmissions could be prevented with better anticipation of symptoms in high-risk ambulatory patients and enhanced communication about symptom burden between patients and physicians before an escalation that leads to an emergency department visit. Managing symptoms in patients who are appropriate for hospice is challenging. Readmission is a marker of poor prognosis.
Copyright © 2016 by American Society of Clinical Oncology.
Figures
Comment in
-
Benefits and Pitfalls of Using Administrative Data to Study Hospitalization Patterns in Patients With Cancer Treated With Chemotherapy.J Oncol Pract. 2016 Feb;12(2):140-1. doi: 10.1200/JOP.2015.008482. J Oncol Pract. 2016. PMID: 26869654 No abstract available.
References
-
- American Cancer Society : Cancer Facts and Figures 2012 http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/docume...
-
- DeSantis CE Lin CC Mariotto AB, etal: Cancer treatment and survivorship statistics, 2014 CA Cancer J Clin 64:252–271,2014 - PubMed
-
- Murphy SL, Xu J, Kochanek KD: Deaths: Final data for 2010 Natl Vital Stat Rep 61:1–117,2013 - PubMed
-
- Peppercorn JM Smith TJ Helft PR, etalAmerican Society of Clinical Oncology : American society of clinical oncology statement: Toward individualized care for patients with advanced cancer J Clin Oncol 29:755–760,2011 - PubMed
-
- McIllmurray M: Hanks G, Cherny NI, Christakis NA, et al.The medical treatment of cancer in palliative care, Oxford Textbook of Palliative Medicine 513–525,2010. Oxford: Oxford University Press
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
